Porcine Epidemic Diarrhea Vaccines Market Report 2026

Porcine Epidemic Diarrhea Vaccines Market Overview

• Porcine Epidemic Diarrhea Vaccines market size has reached to $1.8 billion in 2025 • Expected to grow to $2.5 billion in 2030 at a compound annual growth rate (CAGR) of 6.7% • Growth Driver: The Increase In Pig Farming Fueling Market Growth Due To Expanding Pork Demand And Advancements In Swine Production • Market Trend: Advancements In Next-Generation Solutions Strengthen Protection Against Emerging PEDV Strains • Asia-Pacific was the largest region in 2025.

What Is Covered Under Porcine Epidemic Diarrhea Vaccines Market?

Porcine epidemic diarrhea (PED) vaccines are biological preparations developed to provide immunity against the porcine epidemic diarrhea virus (PEDV), which causes severe gastrointestinal disease in pigs. These vaccines are essential tools in preventing and controlling Porcine Epidemic Diarrhea, contributing to the health and productivity of pig populations and the economic stability of the swine industry. The main products of porcine epidemic diarrhea vaccines are live vaccines and killed vaccines. Live vaccines are biological preparations that contain attenuated or weakened forms of the porcine epidemic diarrhea virus (PEDV). The various applications include piglets, and adult pigs used in various end-users such as veterinary hospitals, and hog production farms.

What Is The Porcine Epidemic Diarrhea Vaccines Market Growth Forecast?

The porcine epidemic diarrhea vaccines market size is expected to see strong growth in the next few years. It will grow to $2.5 billion in 2030 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to growth of intensive pig farming practices, rising global demand for pork products, increasing awareness of herd immunity benefits, expansion of organized hog production farms, supportive government animal health initiatives. Major trends in the forecast period include increasing adoption of preventive vaccination in swine health management, growing preference for live vaccines in endemic regions, rising focus on early immunization of piglets, expansion of vaccination programs in commercial hog farms, greater emphasis on biosecurity and disease control protocols.

Global Porcine Epidemic Diarrhea Vaccines Market Segmentation

1) By Product: Live Vaccines, Killed Vaccines 2) By Application: Piglets, Adults Pigs 3) By End-User: Veterinary Hospitals, Hog Production Farms Subsegments: 1) By Live Vaccines: Oral Live Vaccines, Injectable Live Vaccines 2) By Killed Vaccines: Inactivated Injectable Vaccines, Inactivated Oral Vaccines

What Is The Driver Of The Porcine Epidemic Diarrhea Vaccines Market?

The increasing pig farming is expected to propel the growth of the porcine epidemic diarrhea vaccine market going forward. Pig farming involves raising domestic pigs for meat production, breeding, rearing, managing animals from birth to market weight, and producing and marketing pork products. The rise in pig farming is driven by growing global demand for pork, advancements in breeding and herd management practices, technological improvements in swine production systems, and the expansion of commercial pork markets. Porcine epidemic diarrhea (PED) vaccines play a crucial role in pig farming by helping prevent and manage disease outbreaks, with administration typically occurring during the sow’s gestation period to provide passive immunity to newborn piglets. For instance, in April 2024, according to the U.S. Department of Agriculture, US-based government agency, U.S. pork production was projected to reach 12.7 million metric tons, reflecting increased swine output and supporting the continued expansion of the pig farming sector. Therefore, the increase in pig farming is driving the growth of the porcine epidemic diarrhea vaccine industry.

Key Players In The Global Porcine Epidemic Diarrhea Vaccines Market

Major companies operating in the porcine epidemic diarrhea vaccines market are Zoetis Inc., Merck Animal Health, MSD Animal Health, Elanco Animal Health, Boehringer Ingelheim Animal Health, Ceva Santé Animale, Phibro Animal Health Corporation, IDT Biologika GmbH, Vaxxinova, Qilu Animal Health Products Factory Co. Ltd., Green Cross Veterinary Products Co. Ltd., Nisseiken Co. Ltd., Ourofino Saúde Animal, Medgene Labs, Harrisvaccines Inc., Tecnovax, Komipharm International Co. Ltd., Bioveta a.s., HIPRA, CZ Vaccines

Global Porcine Epidemic Diarrhea Vaccines Market Trends and Insights

Major companies operating in the Porcine Epidemic Diarrhea (PED) vaccines market are focusing on developing innovative solutions such as next-generation inactivated and recombinant vaccines to enhance immunity and provide broader protection against emerging PEDV strains. Next-generation inactivated and recombinant vaccines are advanced vaccines that use either killed viruses or engineered viral proteins to trigger strong, targeted immunity while improving safety and protection against evolving disease strains. For instance, in August 2024, Zoetis Inc., a US-based animal health company, received a grant related to Porcine Epidemic Diarrhea Virus (PEDV) vaccine research and has also been granted a conditional license by the U.S. Department of Agriculture (USDA) for a vaccine to fight PEDV in pigs. These efforts strengthen Zoetis’s role in developing advanced swine health solutions by supporting further research, enhancing vaccine effectiveness, and expanding protection against emerging PEDV strains.

What Are Latest Mergers And Acquisitions In The Porcine Epidemic Diarrhea Vaccines Market?

In November 2024, Phibro Animal Health Corporation, a US-based health company, acquired Zoetis Inc. for an undisclosed amount. The acquisition aims to broaden Phibro’s product portfolio in medicated feed additives and water-soluble products for cattle, swine, and poultry, strengthening its ability to support animal health and nutrition worldwide. It also seeks to increase Phibro’s profitability, expand its revenue base, and provide funding for future investments in the animal health sector. Zoetis Inc. is a pharmaceutical manufacturing company that specializes in manufacturing of porcine epidemic diarrhea vaccines.

Regional Insights

Asia-Pacific was the largest region in the porcine epidemic diarrhea vaccines market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Porcine Epidemic Diarrhea Vaccines Market?

The porcine epidemic diarrhea vaccines market consists of sales of ingelvac PEDV, barricade, PED vax, PEDV shield, and enterisol ileitis. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Porcine Epidemic Diarrhea Vaccines Market Report 2026?

The porcine epidemic diarrhea vaccines market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the porcine epidemic diarrhea vaccines industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.